Ironwood Pharmaceuticals | IRWD - DEBITO





DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Almirall EUR 342.86M 61.94M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amarin USD 0 0 2025-03
Ardelyx USD 208.26M 653K 2026-03
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Incyte USD 39.43M 982K 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 36.51M 500K 2026-03
Moderna USD 1.31B 571M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 367.66M 4.53M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Takeda JPY 4.85T 208B 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12